Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mTORC1-Inhibition Potentiating Metabolic Block by Tyrosine Kinase Inhibitor Ponatinib in Multiple Myeloma. | Cancers (Basel) | 2022 | 35681744 | PubTator, text mining | PubMed |
| Clinical and Molecular Characteristics of 60 Patients With Human Immunodeficiency Virus-Negative Castleman Disease. | Front Immunol | 2022 | 35655778 | PubTator, text mining | PubMed |
| CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. | J Exp Clin Cancer Res | 2022 | 35655258 | PubTator, text mining | PubMed |
| Dysregulation of microRNAs and tRNA-derived ncRNAs in mesothelial and mesothelioma cell lines after asbestiform fiber exposure. | Sci Rep | 2022 | 35654808 | PubTator, text mining | PubMed |
| The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma. | Nat Commun | 2022 | 35650195 | PubTator, text mining | PubMed |
| Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells. | Front Oncol | 2022 | 35646666 | PubTator, text mining | PubMed |
| Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. | Viruses | 2022 | 35632823 | PubTator, text mining | PubMed |
| Metformin and Cancer, an Ambiguanidous Relationship. | Pharmaceuticals (Basel) | 2022 | 35631452 | PubTator, text mining | PubMed |
| From Tissue Physoxia to Cancer Hypoxia, Cost-Effective Methods to Study Tissue-Specific O2 Levels in Cellular Biology. | Int J Mol Sci | 2022 | 35628446 | PubTator, text mining | PubMed |
| Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma. | Cancer Cell Int | 2022 | 35568951 | PubTator, text mining | PubMed |
| SNAT7 regulates mTORC1 via macropinocytosis. | Proc Natl Acad Sci U S A | 2022 | 35561222 | PubTator, text mining | PubMed |
| Rapamycin Ameliorates Radiation-Induced Testis Damage in Mice. | Front Cell Dev Biol | 2022 | 35547814 | PubTator, text mining | PubMed |
| Interaction Between CD34+ Fibrocytes and Airway Smooth Muscle Promotes IL-8 Production and Akt/PRAS40/mTOR Signaling in Asthma. | Front Med (Lausanne) | 2022 | 35547213 | PubTator, text mining | PubMed |
| Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma. | BMC Med | 2022 | 35546399 | PubTator, text mining | PubMed |
| Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFRO. | J Cell Mol Med | 2022 | 35488725 | PubTator, text mining | PubMed |
| A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors. | Proc Natl Acad Sci U S A | 2022 | 35471904 | PubTator, text mining | PubMed |
| Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies. | Expert Rev Proteomics | 2022 | 35466854 | PubTator, text mining | PubMed |
| Development and validation of the psoriasis scale among the system of quality of life instruments for chronic diseases QLICD-PS (V2.0). | Health Qual Life Outcomes | 2022 | 35459208 | PubTator, text mining | PubMed |
| Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model. | Cancers (Basel) | 2022 | 35454789 | PubTator, text mining | PubMed |
| Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications. | Biomolecules | 2022 | 35454163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=22